BioMarin Pharmaceutical is a US headquartered biotechnology company with an Irish operation located at Shanbally, Co. Cork. Production of biologics is planned to commence at the Shanbally plant in 2017. The company already has a cGMP manufacturing plant in California and acquired a Shanbally facility in 2011. Biomarin is a world leader in developing and commercialising innovative biopharmaceuticals for rare diseases driven by genetic causes.
Callaghan Engineering is providing process engineering services to revamp their pressure and gravity drainage systems in order to facilitate future production processes. Initial works involved a front end study to develop a scope of work. This was followed by detailed engineering design with the project scheduled for completion in June 2016.